Joli D Fermo
Overview
Explore the profile of Joli D Fermo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
117
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sperry J, Loeb A, Smith M, Brighton T, Ehret J, Fermo J, et al.
J Thromb Thrombolysis
. 2024 Feb;
57(4):603-612.
PMID: 38409303
Background: Direct oral anticoagulants (DOACs) are the preferred treatment for venous thromboembolism (VTE). However, DOAC use in patients with a BMI greater than 40 kg/m has not been well studied...
2.
Alnewais M, Landolfa S, Bean M, Fermo J
J Prim Care Community Health
. 2023 Sep;
14:21501319231197588.
PMID: 37750044
Purpose: A case of a patient receiving warfarin for pulmonary embolism (PE) concomitantly with rifampin for treatment of active pulmonary tuberculosis (PTB) is presented. A successful clinical intervention whereby the...
3.
Matheson E, Fermo J, Blackwelder R
Am Fam Physician
. 2023 Jan;
107(1):52-58.
PMID: 36689971
Temporomandibular disorders affect between 5% and 12% of the population and present with symptoms such as headache, bruxism, pain at the temporomandibular joint, jaw popping or clicking, neck pain, tinnitus,...
4.
Whitley H, Fermo J, Ragucci K, Chumney E
Pharm Pract (Granada)
. 2017 Jun;
4(4):183.
PMID: 28603577
Background: Medication adherence is an integral aspect of disease state management for patients with chronic illnesses, including diabetes mellitus. It has been hypothesized that patients with diabetes who have poor...
5.
Bodiford A, Kessler F, Fermo J, Ragucci K
SAGE Open Med Case Rep
. 2016 Aug;
1:2050313X13511602.
PMID: 27489634
A 65-year-old male with documented atrial flutter who was taking warfarin chronically returned to the anticoagulation clinic for follow-up, after having been on 10 mg daily for approximately 2 weeks....
6.
Thompson A, Ragucci K, Fermo J, Whitley H
Pharm Pract (Granada)
. 2014 Aug;
7(4):213-7.
PMID: 25136396
Unlabelled: Until recently, Prothrombin Time/International Normalized Ratio (PT/INR) measurements have typically been used to monitor patients on warfarin through institutional laboratories via venous puncture. The Point-of-Care Testing (POCT) device has...
7.
Herndon C, Hutchison R, Berdine H, Stacy Z, Chen J, Farnsworth D, et al.
Pharmacotherapy
. 2008 May;
28(6):788-805.
PMID: 18503406
Chronic nonmalignant pain is a major burden on the health care system in the United States. Frequently, nonsteroidal antiinflammatory drugs (NSAIDs) are used to assist in the management of various...
8.
Whitley H, Fermo J, Chumney E, Brzezinski W
Ther Clin Risk Manag
. 2008 May;
3(3):499-504.
PMID: 18488070
Objective: To determine the influence of various patient-specific factors, use of concomitant medications, and weekly vitamin K intake on total weekly warfarin maintenance dose (TWD). Methods: Information collected, via retrospective...
9.
Whitley H, Fermo J, Chumney E
Pharmacotherapy
. 2006 Apr;
26(5):682-8.
PMID: 16637797
Study Objectives: To assess the effect of flag alerts that were placed in electronic medical records on patients' adherence with National Cholesterol Education Program (NCEP) guidelines for secondary prevention of...
10.
Lee N, Fermo J
Pharmacotherapy
. 2006 Mar;
26(4):583-6.
PMID: 16553520
An 87-year-old African-American man came to the internal medicine clinic for a routine anticoagulation management visit. He had no complaints. His medical history was significant for stage IV-A follicular non-Hodgkin's...